ARTICLE | Clinical News
Iamin gel peptide-copper compound: Completed two Phase III trials
October 3, 1994 7:00 AM UTC
ProCyte Corp. (PRCY), Kirkland, Wash. Product: Iamin gel peptide-copper compound Indication: Diabetic foot ulcers Status: Completed two Phase III trials in 511 patients, with results expected by the e...